SEC Form 4 · accession 0001140361-17-023684
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curt A. Herberts III
Officer — Senior VP & CBO
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 1, 2017 | S | 2,000 | $6.80 | D | 35,345 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- F2Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms.